Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 4, 2014, Pages 654-659

  Lacalle Aurioles, María ^a,b,c   Mateos Pérez, José M ^b,c   Guzmán De Villoria, Juan A ^d   Olazarán, Javier ^d   Cruz Orduña, Isabel ^d   Alemán Gómez, Yasser ^b,c   Martino, María Elena ^b   Desco, Manuel ^a,b,c  

^a UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Alzheimer's disease; Cerebral blood flow; Cerebral blood volume; Magnetic resonance imaging; Mild cognitive impairment; Perfusion imaging

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE COURSE; ENTORHINAL CORTEX; FEMALE; FOLLOW UP; FUSIFORM GYRUS; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PARIETAL LOBE; PARS OPERCULARIS; PARS TRIANGULARIS; PRECUNEUS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; ALZHEIMER DISEASE; BLOOD FLOW VELOCITY; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; EARLY DIAGNOSIS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PERFUSION IMAGING; PROSPECTIVE STUDIES;

EID: 84897571533     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.241     Document Type: Article

References (40)

1. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 2005; 28: 202-208.
2. Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007; 48: 1289-1300.
3. Jobst KA, Smith AD, Barker CS, Wear A, King EM, Smith A et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol, Neurosurg Psychiatry 1992; 55: 190-194.
4. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010; 9: 1118-1127.
5. Gordon JH, Robert FL, Andrew S, Camper DE, Tammy MS, Deborah A et al. Dynamic susceptibility contrast MS imaging of regional cerebral blood volume in alzheimer disease: a promisig alternative to nuclear medicine. Am J Neuroradiol 1998; 19: 1727-1732.
6. Bammer R, Skare S, Newbould R, Liu C, Thijs V, Ropele S et al. Foundations of advanced magnetic resonance imaging. NeuroRx 2005; 2: 167-196.
7. Grubb Jr. RL, Raichle ME, Eichling JO, Ter-Pogossian MM. The effects of changes in PaCO2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke 1974; 5: 630-639.
8. Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer's disease. NeuroImage 2008; 42: 1267-1274.
9. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005; 234: 851-859.
10. Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol 2001; 22: 1030-1036.
11. Uh J, Lewis-Amezcua K, Martin-Cook K, Cheng Y, Weiner M, Diaz-Arrastia R et al. Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity. Neurobiol Aging 2009; 31: 2038-2046.
12. Yoshiura T, Hiwatashi A, Yamashita K, Ohyagi Y, Monji A, Takayama Y et al. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. AJNR Am J Neuroradiol 2009; 30: 1388-1393.
13. Hauser T, Schonknecht P, Thomann PA, Gerigk L, Schroder J, Henze R et al. Regional cerebral perfusion alterations in patients with mild cognitive impairment and Alzheimer disease using dynamic susceptibility contrast MRI. Acad Radiol 2013; 20: 705-711.
14. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
16. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrastenhanced MR imaging. Radiology 1994; 193: 637-641.
17. Li X, Tian J, Li E, Wang X, Dai J, Ai L. Adaptive total linear least square method for quantification of mean transit time in brain perfusion MRI. Magn Reson Imaging 2003; 21: 503-510.
18. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000; 97: 11050-11055.
19. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 2006; 31: 968-980.
20. Collignon A, Maes F, Delaere D, Vandermeulen D, Suetens P, Marchal G. Automated multi-modality image registration based on information theory. In: Information Processing in Medical Imaging. Kluwer Academic Publishers: Amsterdam, 1995, pp 263-274.
21. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-355.
22. Bell MA, Ball MJ. Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities. Acta Neuropathol 1981; 53: 299-318.
23. McDonald CR, Gharapetian L, McEvoy LK, Fennema-Notestine C, Hagler Jr. DJ, Holland D et al. Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiol Aging 2012; 33: 242-253.
24. Hirao K, Ohnishi T, Matsuda H, Nemoto K, Hirata Y, Yamashita F et al. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography. Nucl Med Commun 2006; 27: 151-156.
25. Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. NeuroImage 2005; 28: 1014-1021.
26. Kolbitsch C, Lorenz IH, Hormann C, Schocke M, Kremser C, Zschiegner F et al. A subanesthetic concentration of sevoflurane increases regional cerebral blood flow and regional cerebral blood volume and decreases regional mean transit time and regional cerebrovascular resistance in volunteers. Anesth Analg 2000; 91: 156-162.
27. Kitaguchi H, Ihara M, Saiki H, Takahashi R, Tomimoto H. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease. Neurosci Lett 2007; 417: 128-131.
28. Dickerson BC, Sperling RA. Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia 2008; 46: 1624-1635.
29. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009; 250: 856-866.
30. Koehler RC, Roman RJ, Harder DR. Astrocytes and the regulation of cerebral blood flow. Trends Neurosci 2009; 32: 160-169.
31. Harder DR, Zhang C, Gebremedhin D. Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci 2002; 17: 27-31.
32. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009; 87: 181-194.
33. Wilkinson BL, Cramer PE, Varvel NH, Reed-Geaghan E, Jiang Q, Szabo A et al. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease. Neurobiol Aging 2012; 33: e121-e132.
34. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006; 27: 552-558.
35. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997; 11: 457-465.
36. Henry-Feugeas MC. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction. Med Hypotheses 2008; 70: 866-875.
37. Mueller SG, Schuff N, Weiner MW. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS. NMR Biomed 2006; 19: 655-668.
38. Nakano S, Asada T, Matsuda H, Uno M, Takasaki M. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med 2001; 42: 1441-1445.
39. Van Beek AHEA, Claassen JAHR.. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease. Behav Brain Res 2011; 221: 537-542.
40. Clement F, Belleville S. Compensation and disease severity on the memory-related activations in mild cognitive impairment. Biol Psychiatry 2010; 68: 894-902.